1
/
의
1
AntibodySystem
SKU(재고 관리 코드):DHC21097
Labetuzumab govitecan (ADC)
Labetuzumab govitecan (ADC)
Catalog No.: DHC21097
| Catalog No. | DHC21097 |
|---|---|
| Product name | Labetuzumab govitecan (ADC) |
| Size | 5 mg |
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Description | Labetuzumab govitecan is an ADC consisting of a CEACAM5-directed antibody and SN38 used for the study of various cancers including colorectal cancer. |
| Form | Liquid |
| Purity | >90% as determined by SEC. |
| Clonality | Monoclonal |
| Target | CEACAM5 |
| Purification | Purified by Ion Exchange Chromatography. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | IMMU130, hMN-14-SN-38 |
| Clone ID | Labetuzumab govitecan |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Share
